Efficacy and safety of biphasic insulin aspart 30 combined with pioglitazone in type 2 diabetes poorly controlled on glibenclamide (glyburide) monotherapy or combination therapy: an 18-week, randomized, open-label study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples